Bristol-Myers marketed VEPESID (etoposide) for cancer - LifeScienceHistory.com

Bristol-Myers marketed VEPESID (etoposide) for cancer

Life Science History

In 1983, Bristol-Myers marketed VEPESID (etoposide) for cancer.

Tags:

Source: Bristol-Myers Squibb Company
Credit:

Visit News/History Source

LifeScienceHistory.com offers three advertising package options. Each package lnclude at least two digital images for multiple page placements and maximum exposure! Rates range from just $300 to $500 per month.